HCA Healthcare (NYSE:HCA) Given a $158.00 Price Target by Jefferies Financial Group Analysts

Jefferies Financial Group set a $158.00 price target on HCA Healthcare (NYSE:HCA) in a research note published on Wednesday, April 17th, TipRanks reports. The firm currently has a buy rating on the stock.

HCA has been the subject of a number of other research reports. SunTrust Banks raised their price target on shares of HCA Healthcare to $175.00 and gave the company a buy rating in a report on Wednesday, January 30th. Zacks Investment Research reaffirmed a buy rating and issued a $134.00 price objective on shares of HCA Healthcare in a research note on Monday, December 31st. Stephens assumed coverage on shares of HCA Healthcare in a research note on Monday, January 14th. They issued an overweight rating and a $143.00 price objective on the stock. Leerink Swann lifted their price target on shares of HCA Healthcare from $160.00 to $175.00 and gave the stock an outperform rating in a research report on Wednesday, January 30th. Finally, ValuEngine cut shares of HCA Healthcare from a buy rating to a hold rating in a research report on Wednesday, March 6th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and nineteen have given a buy rating to the company. HCA Healthcare presently has a consensus rating of Buy and a consensus target price of $149.41.

Shares of NYSE HCA traded down $2.11 during mid-day trading on Wednesday, hitting $122.49. 477,025 shares of the stock were exchanged, compared to its average volume of 1,840,740. The firm has a market cap of $43.46 billion, a price-to-earnings ratio of 12.54, a PEG ratio of 1.01 and a beta of 0.75. HCA Healthcare has a twelve month low of $100.25 and a twelve month high of $147.42.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share for the quarter, beating analysts’ consensus estimates of $2.31 by $0.66. The business had revenue of $12.52 billion during the quarter, compared to analyst estimates of $12.34 billion. HCA Healthcare had a net margin of 7.71% and a negative return on equity of 112.65%. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the business posted $3.18 earnings per share. Research analysts expect that HCA Healthcare will post 10.33 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Monday, June 3rd will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.60 annualized dividend and a yield of 1.31%. HCA Healthcare’s dividend payout ratio (DPR) is 16.38%.

In other news, CFO Bill B. Rutherford sold 37,500 shares of the firm’s stock in a transaction that occurred on Tuesday, February 12th. The stock was sold at an average price of $139.65, for a total value of $5,236,875.00. Following the completion of the sale, the chief financial officer now directly owns 58,972 shares of the company’s stock, valued at approximately $8,235,439.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jon M. Foster sold 11,640 shares of the firm’s stock in a transaction that occurred on Tuesday, February 12th. The shares were sold at an average price of $139.68, for a total value of $1,625,875.20. Following the completion of the sale, the insider now directly owns 84,492 shares of the company’s stock, valued at $11,801,842.56. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 77,224 shares of company stock worth $10,765,584. 2.70% of the stock is owned by company insiders.

A number of hedge funds have recently modified their holdings of HCA. Bank of New York Mellon Corp lifted its position in HCA Healthcare by 15.6% during the third quarter. Bank of New York Mellon Corp now owns 2,406,809 shares of the company’s stock valued at $334,834,000 after purchasing an additional 324,724 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of HCA Healthcare by 0.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 527,846 shares of the company’s stock worth $73,429,000 after purchasing an additional 2,534 shares during the period. Standard Life Aberdeen plc lifted its stake in shares of HCA Healthcare by 8.3% in the 3rd quarter. Standard Life Aberdeen plc now owns 113,267 shares of the company’s stock worth $15,759,000 after purchasing an additional 8,677 shares during the period. LPL Financial LLC lifted its stake in shares of HCA Healthcare by 20.5% in the 3rd quarter. LPL Financial LLC now owns 9,753 shares of the company’s stock worth $1,357,000 after purchasing an additional 1,661 shares during the period. Finally, BlueMountain Capital Management LLC bought a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $1,471,000. 71.54% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: What are catch-up contributions?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.